Efficacy of 14 Day OBMT Therapy as a Second-line Treatment for Helicobacter pylori Infection / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 136-141, 2004.
Artículo
en Coreano
| WPRIM
| ID: wpr-213233
ABSTRACT
BACKGROUND/AIMS:
As a second-line treatment for H. pylori eradication in the case of first-line OAC (omeprazole, amoxicillin, clarithromycin) treatment failure, a minimum of one-week OBMT quadruple therapy composed of omeprazole, bismuth, metronidazole, tetracycline has been recommended in European countries and one or two weeks in USA. In Korea, one-week OBMT quadruple therapy is recommended for the case of first-line OAC treatment failure. Because H. pylori eradication rate of one-week OBMT therapy in Korea is about 80%, the eradication rate of one week therapy is not satisfactory. We analyzed the effect of two-week second-line OBMT therapy.METHODS:
Between June 2002 and June 2003, 107 patients who were H. pylori positive (44 males and 63 females mean age 51.8 years) after primary eradication therapy received two-week OBMT therapy. Four weeks after completion of therapy, 13C-urea breath test was performed to detect H. pylori.RESULTS:
After two weeks of OBMT therapy, eradication was achieved in 103 of 107 patients (96.3%) and in 68 of 71 peptic ulcer patients (95.8%).CONCLUSIONS:
Two-week OBMT therapy should be considered as a retreatment regimen with the eradication rate more than 90%.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Tetraciclina
/
Bismuto
/
Omeprazol
/
Resumen en Inglés
/
Helicobacter pylori
/
Infecciones por Helicobacter
/
Retratamiento
/
Quimioterapia Combinada
/
Antiácidos
/
Metronidazol
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS